European Union:
European Commission Issues New Guidelines On Principles Of Good Distribution Practice Of Active Substances For Medicinal Product
To print this article, all you need is to be registered or login on Mondaq.com.
On March 19, 2015, the European Commission published guidelines on principles of Good Distribution
Practice of active substances for medicinal products for human use.
The guidelines provide stand-alone guidance for importers and
distributors. The guidelines will come into operation on September
21, 2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from European Union
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
